INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS

Detalhes bibliográficos
Autor(a) principal: Rezende, Patrícia Mendes
Data de Publicação: 2021
Outros Autores: Coimbra, Marcus Vinicius da Silva
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista JRG de Estudos Acadêmicos
Texto Completo: http://revistajrg.com/index.php/jrg/article/view/279
Resumo: Erectile dysfunction (DE) is known as a man's difficulty in obtaining or maintaining an erection, may have as causes some diseases and conditions such as: depression, diabetes, arterial hypertension, high cholesterol, obesity, coronary disease, disease of Parkinson's, prostate cancer treatment, anabolic steroid consumption, spinal cord injuries, drug addiction, alcoholism, and even stress and anxiety. An accidental discovery of one of the most famous pharmaceuticals in the pharmaceutical industry began at the end of the 80, when the American laboratory Pfizer, who had invested heavily in research and testing to find a drug for hypertension Pulmonary and angina pectoris. So, these studies were terminated in 1992, because the first results suggested that the drug had a small effect on angina. However, it was noted some properties in the Sildenafil citrate that could be a new light on the treatment of erectile dysfunctions. In the 30-day period, in the region's drugstores, approximately 800 individuals aged between 17 and 85 years were treated, where it can be verified that not only people with erectile dysfunction make use of sildenafil and tadalafila. Where 51% of these individuals aged between 17 and 30 years make use of these regular medications, in most cases if they are for recreational use, without a medical indication only for personal reasons such as: increase libido and improve sexual performance.
id JRG_5ad6a67d0df44b3f06e07b8c7ad4296f
oai_identifier_str oai:ojs2.revistajrg.com:article/279
network_acronym_str JRG
network_name_str Revista JRG de Estudos Acadêmicos
repository_id_str
spelling INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERSINDICAÇÃO DE USO INDISCRIMINADO DE SILDENAFILA E TADALAFILA POR JOVENSDisfunção erétil. Sildenafila. Tadalafila.Erectile dysfunction. Sildenafil. tadalafilErectile dysfunction (DE) is known as a man's difficulty in obtaining or maintaining an erection, may have as causes some diseases and conditions such as: depression, diabetes, arterial hypertension, high cholesterol, obesity, coronary disease, disease of Parkinson's, prostate cancer treatment, anabolic steroid consumption, spinal cord injuries, drug addiction, alcoholism, and even stress and anxiety. An accidental discovery of one of the most famous pharmaceuticals in the pharmaceutical industry began at the end of the 80, when the American laboratory Pfizer, who had invested heavily in research and testing to find a drug for hypertension Pulmonary and angina pectoris. So, these studies were terminated in 1992, because the first results suggested that the drug had a small effect on angina. However, it was noted some properties in the Sildenafil citrate that could be a new light on the treatment of erectile dysfunctions. In the 30-day period, in the region's drugstores, approximately 800 individuals aged between 17 and 85 years were treated, where it can be verified that not only people with erectile dysfunction make use of sildenafil and tadalafila. Where 51% of these individuals aged between 17 and 30 years make use of these regular medications, in most cases if they are for recreational use, without a medical indication only for personal reasons such as: increase libido and improve sexual performance.A disfunção erétil (DE) é conhecida como uma dificuldade do homem em obter ou manter uma ereção, podem ter como causas algumas doenças e condições tais como: depressão, diabetes, hipertensão arterial, colesterol elevado, obesidade, doença coronária, doença de Parkinson, tratamento do cancro da próstata, consumo de esteroides anabolizantes, lesões na medula espinhal, toxicodependência, alcoolismo, e até mesmo stress e ansiedade. Uma descoberta acidental de um dos medicamentos mais famosos da indústria farmacêutica teve início no final da década de 80, quando o laboratório americano Pfizer, que havia investido muito em pesquisas e testes para encontrar um medicamento para hipertensão pulmonar e angina do peito. Então esses estudos foram encerrados em 1992, porque os primeiros resultados sugeriram que a droga tinha um pequeno efeito sobre a angina. Entretanto, foi notado algumas propriedades no citrato de sildenafila que poderia ser uma nova luz sobre o tratamento de disfunções eréteis. No período de 30 dias, em drogarias da região foram atendidos em média cerca de 800 indivíduos com idade entre 17 a 85 anos, onde se pode comprovar que não somente pessoas com disfunção erétil fazem o uso da sildenafila e tadalafila. Onde 51% desses indivíduos com idade entre 17 a 30 anos fazem uso desses medicamentos regulares, na maioria dos casos se dá para uso recreativo, sem uma indicação médica somente por questões pessoais como: aumentar a libido e para a melhora do desempenho sexual.Editora JRG2021-07-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo avaliado pelos Paresapplication/pdfhttp://revistajrg.com/index.php/jrg/article/view/27910.5281/zenodo.5093826JRG Journal of Academic Studies; Vol. 4 No. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77JRG Journal of Academic Studies ; Vol. 4 Núm. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77JRG Journal of Academic Studies; V. 4 N. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77Revista JRG de Estudos Acadêmicos ; v. 4 n. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-772595-166110.29327/257411.4.9-1reponame:Revista JRG de Estudos Acadêmicosinstname:Editora JRGinstacron:JRGporhttp://revistajrg.com/index.php/jrg/article/view/279/369https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRezende, Patrícia Mendes Coimbra, Marcus Vinicius da Silva 2022-03-08T14:02:39Zoai:ojs2.revistajrg.com:article/279Revistahttp://revistajrg.com/index.php/jrgPRIhttp://revistajrg.com/index.php/jrg/oaiprofessorjonas@gmail.com||2595-16612595-1661opendoar:2022-03-08T14:02:39Revista JRG de Estudos Acadêmicos - Editora JRGfalse
dc.title.none.fl_str_mv INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
INDICAÇÃO DE USO INDISCRIMINADO DE SILDENAFILA E TADALAFILA POR JOVENS
title INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
spellingShingle INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
Rezende, Patrícia Mendes
Disfunção erétil. Sildenafila. Tadalafila.
Erectile dysfunction. Sildenafil. tadalafil
title_short INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
title_full INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
title_fullStr INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
title_full_unstemmed INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
title_sort INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
author Rezende, Patrícia Mendes
author_facet Rezende, Patrícia Mendes
Coimbra, Marcus Vinicius da Silva
author_role author
author2 Coimbra, Marcus Vinicius da Silva
author2_role author
dc.contributor.author.fl_str_mv Rezende, Patrícia Mendes
Coimbra, Marcus Vinicius da Silva
dc.subject.por.fl_str_mv Disfunção erétil. Sildenafila. Tadalafila.
Erectile dysfunction. Sildenafil. tadalafil
topic Disfunção erétil. Sildenafila. Tadalafila.
Erectile dysfunction. Sildenafil. tadalafil
description Erectile dysfunction (DE) is known as a man's difficulty in obtaining or maintaining an erection, may have as causes some diseases and conditions such as: depression, diabetes, arterial hypertension, high cholesterol, obesity, coronary disease, disease of Parkinson's, prostate cancer treatment, anabolic steroid consumption, spinal cord injuries, drug addiction, alcoholism, and even stress and anxiety. An accidental discovery of one of the most famous pharmaceuticals in the pharmaceutical industry began at the end of the 80, when the American laboratory Pfizer, who had invested heavily in research and testing to find a drug for hypertension Pulmonary and angina pectoris. So, these studies were terminated in 1992, because the first results suggested that the drug had a small effect on angina. However, it was noted some properties in the Sildenafil citrate that could be a new light on the treatment of erectile dysfunctions. In the 30-day period, in the region's drugstores, approximately 800 individuals aged between 17 and 85 years were treated, where it can be verified that not only people with erectile dysfunction make use of sildenafil and tadalafila. Where 51% of these individuals aged between 17 and 30 years make use of these regular medications, in most cases if they are for recreational use, without a medical indication only for personal reasons such as: increase libido and improve sexual performance.
publishDate 2021
dc.date.none.fl_str_mv 2021-07-12
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigo avaliado pelos Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://revistajrg.com/index.php/jrg/article/view/279
10.5281/zenodo.5093826
url http://revistajrg.com/index.php/jrg/article/view/279
identifier_str_mv 10.5281/zenodo.5093826
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv http://revistajrg.com/index.php/jrg/article/view/279/369
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Editora JRG
publisher.none.fl_str_mv Editora JRG
dc.source.none.fl_str_mv JRG Journal of Academic Studies; Vol. 4 No. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77
JRG Journal of Academic Studies ; Vol. 4 Núm. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77
JRG Journal of Academic Studies; V. 4 N. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77
Revista JRG de Estudos Acadêmicos ; v. 4 n. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77
2595-1661
10.29327/257411.4.9-1
reponame:Revista JRG de Estudos Acadêmicos
instname:Editora JRG
instacron:JRG
instname_str Editora JRG
instacron_str JRG
institution JRG
reponame_str Revista JRG de Estudos Acadêmicos
collection Revista JRG de Estudos Acadêmicos
repository.name.fl_str_mv Revista JRG de Estudos Acadêmicos - Editora JRG
repository.mail.fl_str_mv professorjonas@gmail.com||
_version_ 1797068983383359488